- 5 resultaten
laagste prijs: € 76,99, hoogste prijs: € 200,35, gemiddelde prijs: € 156,62
1
Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - Dranoff, Glenn
bestellen
bij booklooker.de
€ 182,50
verzending: € 0,001
bestellenGesponsorde link
Dranoff, Glenn:

Cancer Immunology and Immunotherapy | Glenn Dranoff | Buch | Current Topics in Microbiology and Immunology | HC runder Rücken kaschiert | XIV | Englisch | 2011 | Springer-Verlag GmbH - gebonden uitgave, pocketboek

2011, ISBN: 9783642141355

[ED: Gebunden], [PU: Springer-Verlag GmbH], The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal impo… Meer...

Verzendingskosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) preigu
2
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
bestellen
bij Amazon.de (Intern. Bücher)
€ 198,80
verzending: € 3,001
bestellenGesponsorde link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - gebonden uitgave, pocketboek

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … Meer...

Verzendingskosten:Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00)
3
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
bestellen
bij Amazon.de (Intern. Bücher)
€ 200,35
verzending: € 3,001
bestellenGesponsorde link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - gebonden uitgave, pocketboek

2011

ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … Meer...

Verzendingskosten:Gewöhnlich versandfertig in 2 bis 3 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) buchbaer
4
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)
bestellen
bij Amazon.de (Intern. Bücher)
€ 76,99
verzending: € 3,001
bestellenGesponsorde link
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344) - gebonden uitgave, pocketboek

2011, ISBN: 9783642141355

Springer, Gebundene Ausgabe, Auflage: 2011, 320 Seiten, Publiziert: 2011-04-15T00:00:01Z, Produktgruppe: Buch, 1.43 kg, Immunsystem, Körperteile, Medizin, Kategorien, Bücher, Onkologie & … Meer...

Verzendingskosten:Gewöhnlich versandfertig in 6 bis 7 Tagen. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Paper Cavalier Deutschland
5
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - Dranoff, Glenn
bestellen
bij AbeBooks.de
€ 124,45
verzending: € 30,901
bestellenGesponsorde link
Dranoff, Glenn:
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344) - gebonden uitgave, pocketboek

2011, ISBN: 3642141358

[EAN: 9783642141355], Gebraucht, sehr guter Zustand, [PU: Springer], In Used Condition, Books

NOT NEW BOOK. Verzendingskosten: EUR 30.90 Byrd Books, Austin, TX, U.S.A. [83414208] [Rating: 5 (von 5)]

1Aangezien sommige platformen geen verzendingsvoorwaarden meedelen en deze kunnen afhangen van het land van levering, de aankoopprijs, het gewicht en de grootte van het artikel, een eventueel lidmaatschap van het platform, een rechtstreekse levering door het platform of via een derde aanbieder (Marktplaats), enz., is het mogelijk dat de door euro-boek.nl meegedeelde verzendingskosten niet overeenstemmen met deze van het aanbiedende platform.

Bibliografische gegevens van het best passende boek

Bijzonderheden over het boek
Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Gedetalleerde informatie over het boek. - Cancer Immunology and Immunotherapy (Current Topics in Microbiology and Immunology, 344, Band 344)


EAN (ISBN-13): 9783642141355
ISBN (ISBN-10): 3642141358
Gebonden uitgave
Verschijningsjaar: 2011
Uitgever: Dranoff, Glenn, Springer
304 Bladzijden
Gewicht: 0,605 kg
Taal: eng/Englisch

Boek bevindt zich in het datenbestand sinds 2007-11-22T22:26:21+01:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2024-01-10T18:45:12+01:00 (Amsterdam)
ISBN/EAN: 9783642141355

ISBN - alternatieve schrijfwijzen:
3-642-14135-8, 978-3-642-14135-5
alternatieve schrijfwijzen en verwante zoekwoorden:
Auteur van het boek: dran
Titel van het boek: the topic cancer, cancer immunology immunotherapy, current topics microbiology and immunology, 344


Gegevens van de uitgever

Auteur: Glenn Dranoff
Titel: Current Topics in Microbiology and Immunology; Cancer Immunology and Immunotherapy
Uitgeverij: Springer; Springer Berlin
306 Bladzijden
Verschijningsjaar: 2011-04-15
Berlin; Heidelberg; DE
Gedrukt / Gemaakt in
Taal: Engels
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XIV, 306 p.

BB; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Medizin, Gesundheit; dendritic cells; immune infiltration; regulatory T cells; signal transducer and activator of transcription 3 (Stat3); tumor-immune interactions; Cancer Biology; Immunology; Immunologie; BC

The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These “first-in-class” treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy.
The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Includes supplementary material: sn.pub/extras

< naar Archief...